Literature DB >> 8151568

Secretory immune response and clinical sequelae of Salmonella infection in a point source cohort.

G T Thomson1, M Alfa, K Orr, B R Thomson, N Olson.   

Abstract

OBJECTIVE: To determine the kinetic isotypic serum and secretory immune response to Salmonella enteritidis in a cohort of individuals exposed to the organism in a single food source outbreak of dysentery. To determine the clinical outcome and immunogenetics of the exposed cohort and to correlate these features with the immune response.
METHODS: Following a single point source outbreak of Salmonella enteritidis, a cohort of dysenteric individuals were ascertained using a reactive arthritis screening questionnaire (QUEST). Serum and stimulated saliva samples were obtained at 6, 12, and 24 months following the outbreak of dysentery; examinations were conducted at the same time. Two unexposed control groups were ascertained: (1) general rheumatology clinic patients and (2) well nonarthritic family practice patients. An ELISA to determine quantitative IgA responses to Salmonella enteritidis lipopolysaccharide (LPS) was performed.
RESULTS: Eleven of the 84 exposed individuals with dysentery developed reactive arthritis (ReA) of reactive enthesitis (ReE). There was a prolonged salivary IgA anti-LPS response in both the ReA/ReE and DYS (dysentery alone) patients compared with unexposed controls. A ratio of salivary IgA anti-LPS/serum IgA anti-LPS > 1 was associated with a good outcome (remission) of ReA, whereas a ratio < 1 was associated with chronic disease.
CONCLUSIONS: There is a more prolonged humoral immune response to Salmonella LPS in exposed individuals than hitherto described. A risk factor in the prolongation of ReA is the inability to mount an appropriate specific salivary (secretory) immune response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8151568

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

1.  Kinetics of the human antibody response against Salmonella enterica Serovars Enteritidis and Typhimurium determined by lipopolysaccharide enzyme-linked immunosorbent assay.

Authors:  Mette A Strid; Tine Dalby; Kåre Mølbak; Karen A Krogfelt
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

2.  Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study.

Authors:  T Hannu; L Mattila; A Siitonen; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2004-11-18       Impact factor: 19.103

3.  Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.

Authors:  T Yli-Kerttula; R Luukkainen; U Yli-Kerttula; T Möttönen; M Hakola; M Korpela; M Sanila; J Uksila; A Toivanen
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

Review 4.  Systematic review and meta-analysis of the proportion of non-typhoidal Salmonella cases that develop chronic sequelae.

Authors:  J Keithlin; J M Sargeant; M K Thomas; A Fazil
Journal:  Epidemiol Infect       Date:  2014-10-30       Impact factor: 2.451

5.  Non-typhoid salmonella septic arthritis in dual living liver transplant recipient: a case report.

Authors:  Kun Moo Choi; Cheon Soo Park; Gi-Won Song; Sung-Gyu Lee
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2014-02-24

Review 6.  Factors Associated with Sequelae of Campylobacter and Non-typhoidal Salmonella Infections: A Systematic Review.

Authors:  Oluwaseun B Esan; Madison Pearce; Oliver van Hecke; Nia Roberts; Dylan R J Collins; Mara Violato; Noel McCarthy; Rafael Perera; Thomas R Fanshawe
Journal:  EBioMedicine       Date:  2016-12-08       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.